Suchergebnisse - "Puxeddu, Ermanno"

PubPharm (80)

31

Emerging biological therapies for treating chronic obstructive pulmonary disease : A pairwise and network meta-analysis

enthalten in: Pulmonary pharmacology & therapeutics | 2018

von Rogliani, P. | Matera, M. | Puxeddu, E. | +4

32

A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD

enthalten in: Expert opinion on drug safety | 2018

von Matera, M. | Calzetta, L. | Puxeddu, E. | +2

33

Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD : A pilot study

enthalten in: Pulmonary pharmacology & therapeutics | 2018

von Rogliani, P. | Ora, J. | Puxeddu, E. | +4

34

Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation

enthalten in: PloS one | 2018

von Lee, J. | Arisi, I. | Puxeddu, E. | +7

ErratumIn: PLoS One. 2018 May 17;13(5):e0197794. - PMID 29772026

35

An overview of the current management of chronic obstructive pulmonary disease : can we go beyond the GOLD recommendations?

enthalten in: Expert review of respiratory medicine | 2018

von Cazzola, M. | Rogliani, P. | Puxeddu, E. | +2

36

Adherence to COPD treatment : Myth and reality

enthalten in: Respiratory medicine | 2017

von Rogliani, P. | Ora, J. | Puxeddu, E. | +2

37

Gender-related Responsiveness to the Pharmacological Treatment of COPD : A First Step Towards the Personalized Medicine

enthalten in: EBioMedicine | 2017

von Calzetta, L. | Puxeddu, E. | Rogliani, P.

CommentOn: EBioMedicine. 2017 May;19:139-145. - PMID 28461224

38

Relationship between oxytocin/vasopressin and latex in obstetric surgery : how to recognize (and prevent) allergic reactions and differentiate them from side effects?

enthalten in: The journal of allergy and clinical immunology. In practice | 2017

von Liccardi, G. | Calzetta, L. | Salzillo, A. | +2

CommentOn: J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):773-6. - PMID 27039235

39

Optimizing drug delivery in COPD : The role of inhaler devices

enthalten in: Respiratory medicine | 2017

von Rogliani, P. | Calzetta, L. | Coppola, A. | +5

40

Impact of pulmonary vascular volume on mortality in IPF : is it time to reconsider the role of vasculature in disease pathogenesis and progression?

enthalten in: The European respiratory journal | 2017

von Puxeddu, E. | Cavalli, F. | Pezzuto, G. | +2

CommentOn: Eur Respir J. 2017 Jan 25;49(1):. - PMID 27811068